{
    "2018-04-12": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Why One Drug Flop Tanked Incyte's Stock",
                "features": {
                    "keywords": [
                        "Drug Flop",
                        "Tanked",
                        "Incyte"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "GlaxoSmithKline Buys Novartisâ€™s Stake in Joint Venture",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Novartis",
                        "Stake",
                        "Joint Venture"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "The Swiss Stock Market Climbed As Syria Concerns Ease",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Climbed",
                        "Syria Concerns",
                        "Ease"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Incyte Has Diversified Its Revenues across Multiple Product Lines",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Diversified",
                        "Revenues",
                        "Product Lines"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}